Colin Kings own words16 Mar 2021 20:56
I see many are still perpetuating the myth that ODX are working flat out knocking out tests at max capacity since oct 2020. A reasonable estimate by me last week was that at max capacity, ODX would have produced 9.4M tests by end of last week.
We've had the "they're making antigen tests" for many months now, with many ramping that the mologic test is TTed, and then the latest switch to a ramp that the UK gov test is TTed either/both are being manufactured and it's all hush hush NDA and stuff.
That whole rampiness was killed dead by CK yesterday, when he confirmed what was obvious that there is no selected test, and he said they had no test to make. And we've been told the mologic TT is still progressing
So now I see the ramp targets have moved, and we are back onto, "they've been knocking out RTC anitbody tests for months". At one time that was based on the whole dead cert that a mass vaccination programme would require mass antibody testing, that did not transpire. Then it was based on a ramp that abingdon has a whole raft of pre-orders just looking to be fulfilled, and as soon as the 15th of Feb happened (when the uk gov contract expired), all these orders would be announced. Its a month later, and Abingdon's recent RNS made it clear that they are producing "in anticipation" of orders, i.e. there are no actual sizeable orders. Also ODX has continually told us that they would announced all signficant orders, no announcements have been made.
So that still leaves the rampers with wiggle room that there's NDAed orders for RTC antibody test. The funny thing is, on the 1st of december, when the UK gov contract for antibody RTC test was still thought by many to be the big earner for ODX, and the gov hadn't even thought about commissioning an antigen LFT consortium, an article in the scottish herald stated:-
"Mr King said Omega is anticipating most of the demand in the first part of 2021 will be for rapid antigen tests, which confirm whether a person is currently infected. That is expected to shift in favour of antibody testing – which detects if a person has previously had the disease, and is producing natural defences against it – as the year progresses.
The latter is expected to be used alongside any vaccines that are rolled out, as health experts will want to track the longevity of protection provided by an inoculation."
So, we're at about 1/2 way thru the first 1/2 of 2021, and ODX does not have an antigen LFT test in their portfolio of products, even though CK expected this to be the most in demand test in the first part of 2021, and he didn't expect demand for antibody tests. Monitoring antibody longevity is entirely different from a mass antibody program, any sizeable monitoring program would require UK gov to order tests that give quantative results, which LFTs do not.
https://www.heraldscotland.com/business_hq/18910109.omega-expects-significantly-improved-second-half-posting-1-8m-loss/